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Introduction and Background  
Globally more than 800 women die every day from preventable complications related to pregnancy, childbirth, 
and 99 percent of these deaths occur in developing countries. Every day approximately 7,200 babies are stillborn 
(Lancet 2016). Pre-eclampsia and eclampsia contribute significantly to these mortalities. 
The Bangladesh Maternal Mortality Survey (BMMS) 2010 revealed that eclampsia is the second most common 
direct cause of maternal death in Bangladesh followed by post-partum hemorrhage (PPH); it is responsible for 
about 20 percent of all maternal deaths (Niport 2012). Among the 5,000 to 6,000 maternal deaths each year 
in Bangladesh, 1,000 to 1,200 are due to eclampsia. Through the Ending Eclampsia project, with support from 
USAID, Population Council is seeking to expand access to proven, underutilized interventions and commodities 
for the prevention, early detection, and treatment of PE/E and strengthen global partnerships.  
In resource poor countries, particularly Bangladesh, magnesium sulphate (MgSO4) for management of severe 
PE/E, anti-hypertensives to manage high blood pressure during pregnancy, aspirin prophylaxis for pregnant 
women at high risk of developing PE/E, task shifting to lower level cadres, and community involvement have not 
been optimally examined. There has been no systematic review of research and programming on PE/E 
prevention, early detection, and treatment in Bangladesh. Until recently, PE/E policy and the perception of the 
health system and communities were unknown to program implementers and service providers.  
To appreciate the enormity of the problem at the country level, Population Council conducted a landscape 
analysis on PE/E in Bangladesh in August and September 2015 to:  
• Understand the level of program and policy support for PE/E prevention and treatment; 
• Analyze the gaps in providers’ competence for preventing, detecting, and managing PE/E; 
• Determine primary health facilities’ capacities for managing PE/E; 
• Assess communities’ PE/E awareness, beliefs, and experiences; 
• Understand the volume of research on PE/E in the last 15 years; and 
• Determine priority areas for PE/E research and program interventions.  
The Council collected data on information on PE/E policy support, current program elements addressing PE/E in 
the country, antenatal and maternity care facilities’ capacities for detecting and managing PE/E, the availability 
of essential tools and life-saving commodities at health facilities, communities’ beliefs and misperceptions 
hindering pregnant women’s timely care, and research gaps, to improve health care for PE/E prevention and 
management. This report provides major findings of the landscape analysis for Bangladesh and suggests priority 
areas for interventions.  
BOX 1   Health system structure in Bangladesh 
Tertiary hospitals              Medical College and Specialized Hospitals 68 
Secondary facilities District Hospital (DH) 
   Mother and Child Welfare Center (MCWC) 
   Upazila Health Complex (UHC) 
632 
Union Health and Family Welfare Centers (UH&FWCs) 3,942 




― DHs are designed to provide all medical and surgical services including comprehensive emergency 
obstetric care (CEmOC). 
― MCWCs provide mother and child health services including normal delivery and caesarian section, and 
all family planning (FP) services. 
― UHCs are designed to provide all general and minor surgical services including all FP services; some 
UHCs are also upgraded for Comprehensive Emergency Obstetric Care (CEmOC) services. 
― UH&FWCs are designed to provide antenatal care (ANC), postnatal care (PNC), short acting 
contraception, and child health services. Some UH&FWCs are also upgraded for normal delivery and 
long acting and reversible contraception (LARCs) and permanent contraception. 






This cross-sectional study encompasses a systematic review of available literature and collection of primary data 
from a range of audiences using both qualitative and quantitative methods. About one-third of these activities 
were supported by MacArthur Foundation grants and the remaining two-thirds by USAID through the Ending 
Eclampsia project.  
In reviewing PE/E related literature, researchers collected and analyzed all published literature on PE/E from 
2000 to 2015. Policy and program level data were gathered at the national and district levels through 
interviewing related policy makers, managers of MNH programs, and representatives of the related local and 
international NGOs. At the district level, District Hospitals (DH) and Mother and Child Health Centers (MCWC) 
were selected from all districts. At the upazila/sub-district level, three sub-districts were selected for the study. 
At the sub-district level, all facilities were selected for the study. The district and sub-districts were selected 
purposively in consultation with the Ministry of Health and Family Welfare (MOHFW).  
At each study facility, researchers interviewed providers working in antenatal, maternity, or labor/delivery wards, 
conducted facility inventories, and observed client–provider interactions of ANC consultations prior to 
interviewing the same pregnant women leaving the facility. Women (18–49 years of age) and men (18–55 years) 
participated in focus group discussions (FGDs). In-depth interviews were conducted with women who had 
experienced eclampsia and survived with a living newborn. The data collection activities can be classified and 
presented in three broad thematic areas: policy, health system, and community.  
Policy  
• Desk review of published and unpublished documents on PE/E from 2000 to 2015;  
• In-depth interviews (IDIs) with policymakers, development partners, and Ob/Gyn professionals; and  
• E-Survey of reproductive health (RH) program managers in the country.  
Health system  
• Personal interviews with health care providers; 
• Observations of client and provider interactions during ANC consultations; 
• Client exit interviews after ANC consultations; and 
• Facility inventory.  
Community  
• Focus group discussions (FGDs) with married men and married women; and 






The study was conducted in four districts (figure 1) and selected sub-districts. The study protocol was reviewed 
and approved by the Population Council IRB in New York, with additional reviews and approvals by the 
Bangladesh Medical Research Council (BMRC) and the Ethical Committee of Dhaka Medical College. Informed 
consent was taken from all participants before conducting any interviews. 
Before beginning the study, approval and administrative orders were collected from both Directorate General of 
Family Planning (DGFP) and Directorate General of Health Services (DGHS). A 24 member data collection team 
including four supervisors were recruited and trained for ten days on the study objectives, study tools, 
procedures, and ethical issues. The researchers were given hands-on training for one day in the field other than 
the study area. All filled in questionnaires were checked by the supervisors in the field and sent to the Council 
office for entry and analysis. Data entry was conducted using CSPro and analysis was conducted using SPSS/SAS 
software. The results are presented in this report as frequencies and percentages. Qualitative data were 
collected through using hand-written notes, supported by tape recordings and transcribed for content and 
thematic analysis using Atlas-ti.  






























































Districts & Upazilas:  
Rangpur:  Kaunia, Gangachara & Pirganj 
Tangail:  Kalihati, Madhupur & Bashail 
Comilla:  Daudkandi, Burichong & Debidwar 




Table 1 shows the distribution of facilities and interviews by district and type of data collection. In addition a total 
of 17 national level in-depth interviews (IDIs), 33 districts level IDIs, 8 focus group discussion (FGD) and 22 case 
studies with eclampsia survivors were conducted.  
TABLE 1   Distribution sample by district (quantitative) 
Name of District  Type of data 
Type of Facility (number)  
DH MCWC UHC UH&FWC Total 
Comilla Inventory 1 1 3 36 41 
 SP interview 4 3 19 66 92 
 CPI 5 4 6 67 82 
 Exit interview 5 4 6 67 82 
 Total 15 12 34 236 297 
Rangpur Inventory 1 1 3 27 32 
 SP interview 4 3 17 44 68 
 CPI 5 4 6 48 63 
 Exit interview 5 4 6 48 63 
 Total 15 12 32 167 226 
Tangail Inventory 1 1 3 27 32 
 SP interview 4 3 21 52 80 
 CPI 5 4 6 48 63 
 Exit interview 5 4 6 48 63 
 Total 15 12 36 175 238 
Bhola Inventory 1 1 2 25 29 
 SP interview 4 3 12 30 49 
 CPI 5 4 4 47 60 
 Exit interview 5 4 4 47 60 
 Total 15 12 22 149 198 
 Facility Inventory 4 4 11 115 134 
 SP interview 16 12 69 192 289 
 CPI 20 16 22 210 268 
 ANC exit interview 20 16 22 210 268 
Total  60 48 124 727 959 
Distribution data collection by district (qualitative) 
National IDIs      17 
District IDIs      33 
FGDs      8 





Health service providers  
For analysis and better representation of the data service provider responses were grouped into two categories 
(i.e. service providers’ comparable levels of knowledge and skills):   
• Obstetric/Gynecologists (Ob/Gyns) specialists and Medical Officers (MOs) at the MCH unit; Medical Officers 
Maternal and Child Health (MOMCHs), Indoor Medical Officers (IMOs), Emergency Medical Officers (EMOs), 
Resident Medical Officers (RMOs), or  
• Nurses/midwives, Family Welfare Visitors (FWVs), and Sub-Assistant Community Medical Officers (SACMOs) 
or Paramedics.  
Moreover, the health facility was also categorized within two levels:  
• Secondary facilities: District Hospital (DH), Maternal Child Welfare Centre (MCWC), and Upazila Health 
Complex (UHC), or  
• Primary facilities: Union Health and Family Welfare Centre (UH&FWC).  
Table 2 (page 9) presents the background characteristics of service providers (n=289). The majority of the 
doctors (57%) and other service providers (65%) are female. Over half of the doctors are younger than 40 years 
old, most other service providers are older than 40. Most doctors work at the secondary level facilities and most 
of the other cadres work at PHC facilities. More than half of the doctors have worked in the same unit for less 
than five years while 83 percent of the other service providers have worked in the same unit for more than five 
years. Around one third of the doctors and over half of the other service providers received any training on FP 
and maternal, newborn and child health (MNCH) within the previous three years. Of those who received training, 
about one quarter of the doctors and one fifth of the other cadres received training on emergency obstetric care 
(EmOC).  





TABLE 2   Background characteristic of service providers (n=289) 
Characteristics 
Types of provider (%)  
Doctor 
 n = 98 
Other service 
providers 
n = 191 Total 
Sex    
Male 43 35 37 
Female 57 65 63 
Age in years  
<30 years 25 11 15 
30-39 30 9 14 
40-49 29 39 36 
>49 15 41 34 
Type of facility    
Secondary level 86 14 34 
Primary level 14 86 66 
Duration of work in this ward/unit    
<=1 30 5 12 
1-5 28 12 17 
5-10 8 3 4 
>10 34 80 67 
Types of provider Secondary Primary Total 
OB/GYN specialist/MO 24 0 8 
MO/MOMCH/IMO/EMO/RMO 45 6 19 
Nurses/midwives 14 0 5 
FWV/SACMO/Paramedic 16 94 68 
Training on FP, maternal, newborn and child health in last three years* 
Yes 33 56 50 
No 67 44 50 
Type of training received*    
Emergency obstetric care 27 22 23 
Antenatal care 19 27 26 
Safe delivery care/ Skill Birth Attendant 
training 27 33 32 
Postnatal care 15 27 25 
Helping babies breathe/Essential newborn 
care 44 39 40 
Family planning 35 43 42 
Expanded immunization program 50 45 46 
Nutrition/breastfeeding 6 12 11 
Laboratory investigations 4 0 1 
   Others (infection prevention and computer 
skills) 0 4 4 




ANC client characteristics 
Background characteristics of the 268 ANC clients who participated in the exit interviews are detailed in Table 
3. One fifth were under 20 years and almost two thirds were 20 to 29 years. All ANC clients were married. Ninety-
two percent of the clients had primary or above level education, while only eight percent had no education. More 
than one third of ANC clients were of low socio-economic status (SES) and middle SES, and 30 percent were of 
high SES.  
TABLE 3   Background characteristics of ANC exit clients (n=268) 
Characteristics    
Age %  Pregnancy duration (week) % 
<20 20 <13 5 
20-24 36 13-20 29 
25-29 28 21-28 33 
>29 16 >28 33 
Education  Current ANC visit 
Never attended school 8 1 34 
Primary 29 2 28 
Secondary 51 3 17 
College 10 4 and above 21 
University 2   
No. of pregnancy   Socio-economic status  
1 37 Lower tercile 35 
2 37 Middle tercile 35 
>2 26 Upper tercile 30 













IDENTIFYING AND REVIEWING PROGRAMS AND RESEARCH  
ON PRE-ECLAMPSIA AND ECLAMPSIA IN BANGLADESH  
Clinical practices for PE/E are more or less established for tertiary and secondary facilities in Bangladesh. With 
high rates of maternal mortality due to PE/E, more emphasis is required at primary health care (PHC) and 
community levels to address lower level management and understand health care seeking strategies among 
pregnant women and communities.  
• Researchers conducted a desk review of published and unpublished articles and program materials from 
various sources on PE/E particularly related to community level interventions in Bangladesh. Only 17 
articles conducted in Bangladesh including clinical trials between 2000 and 2015 were found. Only one 
resource described training of community-level service providers, and three published research materials 
were identified that described studies implemented at the community level; 1 2 3  
In addition, researchers reviewed descriptions of two current projects, implemented at the community level 
(unpublished):  
• Lutheran Aid to Medicine in Bangladesh (LAMB) - Integrated Rural Health and Development: A loading dose 
of MgSO4  administered to the severe PE and Eclampsia patients detected at ANC implemented in 3 
upazilas of Dinajpur and Rangpur districts4; and  
• CARE-GSK Community Health Worker Initiative: availability of loading dose of MgSO4 for Private Community 
Based Skilled Birth Attendants (P-CSBAs). This project is implementing in all sub-districts of Sunamganj 
district, the most remote district of Bangladesh.5  
Analysis of the contents of the other 17 studies revealed that six 
studies have examined profiles of eclampsia patients, seven studies 
examined maternal and fetal outcomes of PE/E patients, one study 
examined clinical features of eclampsia patients, three studies 
examined loading dose of MgSO4 at the community level, one study 
examined loading dose versus standard regime of MgSO4 and one 
study examined the effect of MgSO4 vs diazepam in PE/E patients 
(Population Council 2015).  
  
                                                          
 
 
1  Shamsudin et al 2005; OGSB, DGFP 
2  Population Council 2013; 
3  Save the children and ICDDRB 2015 
4  www. lambproject.org   
5  http://familyplanning. care2share. wikispaces. net/file/view/GSK+1+page+brief_FINAL. pdf 







COMMUNITY-BASED STUDIES ON PRE-ECLAMPSIA AND ECLAMPSIA 
Review findings of the community-based studies reveal that a number of factors are responsible for maternal 
mortality and morbidity due to PE/E at the community level, including lack of knowledge and misconceptions 
about PE/E’s causes and treatment, initial intention to seek care from Imams, traditional healers, spiritual 
healers, or village doctors, lack of ANC care, delay in decision making, delay in reaching appropriate facility to 
receive treatment, lack of trained or skilled service providers including community service providers in detecting 
and managing PE/E patients, lack of knowledge on the correct use of MgSO4, poor quality of care of ANC, and 
delays in providing appropriate services.  
The three community studies are: 
(Prof. Latifa et al. 2005.) Use of Parenteral Magnesium Sulphate in Eclampsia and Severe Pre-eclampsia 
Cases in a Rural set up of Bangladesh 
This quasi-experimental study assessed the provision of a loading dose of MgSO4 injection to women with severe 
PE/E patients at community level in a rural context (Tangail, Netrokona and Jamalpur districts), followed by 
referral to a hospital. This study was conducted over a period of six months with 265 women with severe PE/E. 
In the intervention group, 133 women received the loading dose of MgSO4 before referral to hospital. The other 
132 patients in the non-intervention group were referred immediately to a hospital and did not receive the 
loading dose of MgSO4 at the community facility. Administration of the loading dose of MgSO4 successfully 
controlled convulsions in 94 percent of the intervention group and 74 percent in non-intervention group. 
Significantly fewer (p<0.005) women died in intervention group (2.3%) than in the non-intervention group 
(10.4%). Moreover significantly fewer (p<0.001) babies (13.7%) were stillborn (13.7%) in the intervention group 
than in the non-intervention group.  
(OGSB, DGFP and Population Council. 2013.) Operationalizing the Proposed National Protocol  
for the Prevention and Management of Severe Pre-Eclampsia and Eclampsia Patients Using Loading Dose  
of Magnesium Sulphate at Community Level in Bangladesh 
This was conducted to operationalize a proposed national protocol for the prevention and management of severe 
PE/E patients using loading dose of MgSO4 at the community level. The study was a quasi-experimental pre-post-
test design without any control group and was conducted in public facilities with public providers in real life 
situations. The objective of the study was to assess the ability of community-based service providers to screen 
and detect PE/E patients and administer the loading dose of MgSO4 and refer patients to referral facilities. The 
intervention included training service providers on detecting and managing PE/E (measuring blood pressure, 
testing urine for albumin, and administering loading dose of MgSO4). Findings showed that knowledge of 
community-based service providers on PE/E has increased significantly due to this intervention. While there were 
no documented PE/E patients before the intervention in the study facilities, 33 PE/E patients were identified 
and correctly treated and referred during the intervention period. No deaths occurred among mothers or their 
newborns who received the loading dose of MgSO4 at the community level facility; among mothers and newborns 
at the hospitals, one newborn died. Due to lack of manpower, the study could not follow up patients who were 
advised to visit a doctor for further evaluation and take anti-hypertensives. There is a need to understand 
adherence to advice and what a patient actually does at home after PE/SPE/E diagnosis.  
(Save the Children (Mamoni Project) and ICDDR,B. 2015.) Community-based Prevention and Treatment  
of Severe Pre-eclampsia and Eclampsia 
The study was a case-control study in Habigonj district, with three sub-districts selected for intervention and four 
sub-districts for comparison. The study objective was to identify and manage SPE/E cases at the community 
level through trained community-based health providers, administer MgSO4 prior to hospital referral, and 
understand the factors that influence the identification and use of MgSO4 in severe PE/E. The intervention 
included training of service providers on detecting and managing PE/E, measuring blood pressure (BP), testing 
urine for albumin, administering loading dose of MgSO4, and referring PE/E patients to higher level facilities. In 




from the second trimester of pregnancy for the primary prevention. The final report of the study is not yet 
available. However, presentations from the study findings revealed that 33 percent of all severe PE/E cases 
were identified at the intervention sites and only 13 percent at the control sites. Eighty-eight percent of the 
identified cases received the loading of MgSO4 at the community facility. The study also found poor ANC 
coverage, poor quality of ANC services and lack of supervision structure at the study sites. Study recommended 
for the loading dose of MgSO4 through H&FWC at community level and suggested inclusion of loading dose of 
MgSO4 for the community implementation into the policy with a further evaluation strategy.  
All three studies demonstrated improvements in detecting, preventing and managing PE/E at the community 
level. The evidence has contributed to the government’s intention to approve the expansion of loading dose of 
MgSO4 at the community level through UH&FWC level service providers. MoH&FW has suggested revising the 
community level protocol for future implementation. The national protocol for loading dose of MgSO4 for the 
community level is a one page algorithm that portrays key diagnosis features and regimens for the management 
of PE/E. It dictates how to diagnose and what to do. The community service providers (i.e. FWV, SACMO, CSBA, 
paramedics) involved in these studies recommended further simplification of the algorithm.  
POLICY AND PROGRAM MANAGER PERSPECTIVES  
Although trained and skilled providers are available at the secondary and tertiary level, MOH&FW was concerned 
about technical capacity of the community level providers to administer MgSO4 and to monitor the safety and 
toxicity of the drug.  
Researchers conducted in-depth interviews (IDIs) with policy level stakeholders, these included policy makers, 
program managers, development partners and implementers, and other relevant organizations. The purpose 
was to identify the nature and extent of their involvement (including the commitments of the national, district 
and sub-district level program managers), current policies and their use, and to determine the bottlenecks within 
the health system. The analysis also aimed to identify potential areas of synergy with other ongoing efforts.  
Fifty IDIs were conducted at the national level as well as district and sub-district level. Interviews were held with:  
― Director, Primary Health Care & Line Director MNC&AH, DGHS, MoH;  
― Director, MCH-Services and Line Director MCRAH, DGFP, MoH;  
― Deputy Director, Maternal and Child Health (MCH), MCH Unit, DGFP, MoH;  
― Joint Secretary, Family Planning, MOHFW;  
― Joint Chief, ECNEC, MoH;  
― Director, Directorate General of Drug Administration, MoH;  
― Civil Surgeon (CS); 
― Deputy Director of Family Planning (DDFP); 
― Deputy Civil Surgeon (DCH), MoH;  
― Upazila Health and Family Planning Officer (UH&FPO), MoH;  
― Upazila Family Planning Officer (UFPO), MoH;  
― Assistant Director, Family Planning, DGFP, MoH;  
― President and Secretary General of Obstetric & Gynecological Society of Bangladesh (OGSB);  
― Development partners;  
― NGOs representatives; and  
― Other implementers who are particularly working on maternal health.  
Findings from the 50 interviews are summarized in seven sections: impact of PE/E on MCH, government policy 




Impact of PE/E on maternal and child health 
When asked about the causes and relative burden of PE/E in this country, about half (n=21) of the 50 
respondents replied lack of awareness of the pregnant women and not receiving ANC during pregnancy 
contribute to the high levels of PE/E. More than three fourths (n=40) mentioned that PE/E contributes to 
premature delivery, miscarriage, stillbirth, liver damage and death. One informant said: 
“Due to family barrier [in-laws do not allow them to come], pregnant women do not take ANC services 
properly and do not visit us. Usually [they] come at the last moment, when the disease becomes severe. 
They [pregnant women and their families] do not have any knowledge about pre-eclampsia and 
eclampsia. They think of it as a simple matter.”                            UH&FPO, Program Manager, sub-district  
Government policy  
The government policy on PE/E falls under the 
broader issue of maternal health. The government 
has a Standard Operating Procedure (SOP) which 
specifies the prevention and management of PE/E 
at the secondary and tertiary levels. However, the 
government has yet to formalize any policy on PE/E 
prevention and management at community level. A 
protocol has been developed, tested and approved 
for implementation in the field but has not yet been widely circulated and many program managers and service 
providers are unaware of this policy.  
Almost all of the informants stated that they were actively working together to prevent, manage and refer PE/E 
patients. It appears that PE/E management services are consistently available in the tertiary level hospitals 
including all DHs. MCWCs (secondary level) do not admit PE/E cases but refer the cases to DHs. No UHC and 
H&FWC cater to women with severe PE/E (except for those who have CEOC services) rather, they refer pregnant 
women to the higher level facilities. Policy makers and program managers are confused about the existence of 
the PE/E policy. A majority of the informants (n=31), from all levels mentioned they are not aware of any policy 
addressing the PE/E in Bangladesh and do not have copies of the policy or written instructions. One of the policy 
makers said: 
“I don’t know about the government policy. There might be one. I cannot tell you about the policy as I 
didn’t get it yet. I didn’t get the policy in my hand so that I don’t know about where the policy is being 
implemented. There is no implementation policy in my district or upazilas.”  
Policy Maker and Program Manager, MoHFW 
Contradicting this, another policy maker mentioned: 
“As far as I know, the policy is being implemented all over Bangladesh otherwise reaching the targets 
of MDGs 4 and 5 were not possible. Of course we are involved in it, we are providing health care services 
to all types of patients from national, district and sub-district health facilities.”  
Program Manager and Policy Maker, MoHFW  
Another stated: 
“Definitely there is government policy regarding PE/E particularly for the secondary and tertiary level 
facilities. That is national SOP [Standard operating procedure for maternal health issue] which was 
already developed in 2014 and endorsed. However, government does not have any policy for the 




Policies are not  
adequately communicated  




Task shifting  
Interviewees were informed about the evidence about task shifting for the detection and management with 
loading dose of MgSO4 and referral to the higher facilities by the PHC providers (which includes FWV and SACMO). 
Almost all of the policy level respondents (n=49) think that task shifting to lower cadre providers is a good 
decision but they strongly suggest proper training and mentoring of these lower level providers. While most of 
the respondents have reservations about the abilities of Community Skilled Birth Attendants (CSBAs), one 
supported including CSBAs if properly trained. All respondents had reservations about Community Health Care 
Providers’ (CHCPs) abilities to safely and accurately administer the loading dose of MgSO4. The respondents also 
highlighted the importance of recognizing MgSO4 toxicity and its management. Improving the quality of ANC and 
PNC visits is needed, as detection at PHC level is rare. One informant said: 
“We say that we made progress in MDG goals. But, still 50 percent of deliveries are taking place at 
home and if there is any problem, they first come to the grass root level health workers such as the 
FWV, CSBA and SACMO. Women usually go to H&FWC or UHCs or DHs. If we can make the service 
providers more aware and train them at the community level, then they can identify PE/E, administer 
the loading dose of MgSO4, and refer. Then it will definitely have a good effect and will reduce maternal 
mortality.”                                                                                     UNFPA Development Partner Representative  
Another stakeholder countered:  
“We need to think whether permission should be given to PHC providers for providing MgSO4 injection. 
PHC providers can detect PE/E by measuring blood pressure and urine test. That is simple. After that 
they can refer the patients to higher facility. But allowing that level of service providers to administer 
the injection; we definitely need to think about it, because, we have seen abuse. We do not have any 
mechanism to stop the abuse. Likewise doing this, are we causing harm?”                Researcher, ICDDR,B  
Essential drugs for PE/E 
Magnesium sulphate, calcium gluconate and anti-hypertensive drugs are essential to provide comprehensive 
treatment of PE/E. The DGFP never supplies these drugs to its facilities, rather they expect pregnant women 
presenting with PE/E to be referred to a higher level facility. In the DGHS, MgSO4 and calcium gluconate (which 
is used as the antidote to MgSO4 toxicity) are supplied irregularly by the Central Medical Store of Drugs (CMSD) 
to District Reservation Store (DRS). If these medicines are supplied to the DRS, they are either stored there or 
sent to the DHs or UHCs depending upon the need. Anti-hypertensive drugs (Losartan potassium, Atenolol, 
Amlodipine, Methyldopa) are usually purchased quarterly using the 20% allocated money through CMSD or by 
local purchase through a competitive bidding process. Again, purchase should be done from Essential Drug 
Company Limited (EDCL) if the specific drug is manufactured by them. When asked, more than half (n=31) of 
the respondents replied these drugs are not available in their facilities because these are not supplied by central 
level. One informant said: 
“Magnesium Sulphate, calcium gluconate and anti-hypertensive drugs are not supplied to our Family 
Planning department. It may be supplied to Health department. We usually prescribe medicines for the 
pregnant women who come for treatment.”                                                        Medical Officer, MCH, 
DGFP 
Most of the informants believe that the quality of the drugs is good because the government has strong 
mechanisms to control quality. One of the informants said: 
“The quality of drugs is certainly very good, because government has a distinct department to ensure 
the quality and maintain standard. They regularly supervise and pharmaceutical companies need 
certification from Drug Administration. ”                                                  Policy Maker and Program 
Manager  
All district health program managers stated that they have regular and current supply of these essential drugs. 




and a few only have Atenolol or Amlodipine as anti-hypertensive drugs. Sometimes even tertiary hospitals have 
irregular supplies of MgSO4 from the central level. A policy maker and program manager at the central level said: 
“The main thing is all these three drugs are cheap, but the problem is these are used less frequently 
and that’s why they are not OTC drugs [over the counter]. One ampule MgSO4 costs Tk. 18 to 20 [~$0. 
23 USD], aspirin and calcium gluconate are also cheap. However, MgSO4 is not an easily available drug 
all over Bangladesh. We have supplies of aspirin in GoB system. EDCL doesn’t manufacture MgSO4 and 
we purchase from Gonoshastho but they don’t have enough MgSO4 supplies at the Medical College 
Hospitals. Nalepsin, a product of Beximco Pharma, do not have adequate doses for managing 
Eclampsia, thus it is not recommended.”                                                                       Policy Maker, MoHFW  
In exploring the reasons for irregular supply of these drugs, it appears that where the incidence of PE/E is lower, 
facilities are not using the drugs frequently, and any drugs in stock are expiring. Moreover, only a few 
pharmaceutical companies produce MgSO4 which can only be stored for three years. The Directorate General of 
Drug Administration (DGDA) reported that there are eight enlisted pharmaceutical companies (EDCL, 
Gonoshasthaya, Beximco, Opsonin, Incepta, Libra, Chemist and Reneta) that are producing MgSO4 as an 
injectable (2.5 g/5ml) or Intravenous (IV) infusion (4g/100 ml) forms. One informant said: 
“MgSO4 is very much affordable but it is not available. If it was available, then it would be accessible. A 
few pharmaceuticals are producing the drugs. The pharmaceuticals think it is not commercially viable 
as the demands is less. That’s why they do not produce it. Therefore, government has to take the 
initiative since it not a matter of profit to them.”                                                             Researcher, ICDDR,B  
It appears that Civil Surgeons from DGHS and MOMCH-FP from DGFP have the local level purchasing authority. 
No other program managers from the upazila level have the authority to make purchases; they can only inform 
the district authority of their needs. The district authority then locally purchase and supply to the upazila 
according to their need. Out of 37 district and sub-district level public program managers, only seven from district 
and upazila levels have the drug purchasing authority.  
“It is purchased by the health department. MCWCs are not allowed to purchase it, they can advise and 
refer the cases. DDFP cannot purchase it, but MO-MCH has the power. There is a committee to purchase 
medicine, ADCC is the chairman and MO (Clinic) is the member secretary and FPO is the member.” 
Policy Maker and Program Manager, MoHFW 
Government policy on prophylaxis (aspirin and calcium supplements)  
for pregnant women at high risk of PE/ E  
The World Health Organization (WHO) and other global and national professional associations have approved 
use of aspirin during ANC for pregnant women who are at risk of developing PE/E (WHO guidelines, FIGO, 
American Ob/Gyn, and RCOG). A few obstetricians are prescribing aspirin as prophylaxis in their own practice; 
however, they suggested that while PHC providers can provide calcium supplements as a prophylaxis, they felt 
that the PHC providers should refer critical cases to an Ob/Gyn to determine whether aspirin should be 
prescribed. A majority of the respondents (n=40) had no idea about this international guideline or whether there 
is a government policy on use of aspirin as prophylaxis for managing PE/E during ANC. Four respondents who 
have some knowledge on using aspirin as prophylaxis mentioned that this needs to be incorporated into the 
government policy. Two policy makers from Directorate General of Family Planning clearly mentioned that there 
is no policy on use of aspirin prophylaxis for high risk pregnant women.  
“Nothing has been discussed in the National Technical Committee meeting at Directorate General of 
Family Planning. As a program manager, I need to know and analyze well and finally discuss in the NTC 
meeting. Approval from NTC is needed and Eclampsia Technical Committee approval is also needed.” 






Improving the referral system 
The interviewees were divided on the question of a functioning referral system. About half (n=28) of them thought 
that the existing referral system is weak and needs to be strengthened while the remaining respondents (n=22) 
believe that the referral system is functioning. Though even those who think that the current system functions, 
they perceived a need for further strengthening of the referral system.  
It should be noted, however, that very few of the respondents have a proper understanding of the referral process 
for obstetric emergencies from the community to a specific facility where emergency obstetric care is available, 
and then back home with provision of follow up care. Some of the important measures suggested for improving 
referral pathways include training, supervision and monitoring of service providers, vehicle arrangement, use of 
referral slips, raising community awareness, financial incentives to the service providers through demand-side 
financing, financial support to the pregnant women, and using mobile technology. One informant opined that: 
“It is the era of mobile. You just have to pick it up. Certainly you need to have the number. You will just 
call and tell them that I am referring a patient, please attend her and these are the problems. It is not 
a big thing. In other countries we observe that this type of referral system is working and lives of many 
people are being saved.”                                                                                                Medical Officer, DGHS 
Another informant suggested: 
“The referral system needs to be established in a way that they refer to a functional and effective place. 
Not to a UHC, where there is nothing…they could refer to the DH instead of UHC. In that case they need 
to have a linkage. FWVs need to have a linkage with district, upazila, or general hospital. They need a 
written list of mobile numbers of the referral facilities. Patients will return after treatment from the 
facility where they were referred. Since you referred them, therefore they need to come back to you for 
follow up. Otherwise, there is no document whether they have gone. Or more follow up might be needed. 
Those follow up services can be provided by the one who referred. Again, she needs to return back 
there. Or definitely, there should be a tracking system.”                                                   Donor Representative 
One policy maker stated: 
“Yes, there are many barriers in the referral system. In the health system, the entry point and exit point 
for a patient are not fixed. For the common cold, patients are going to Dhaka Medical College Hospital 
as well as to Community Clinics. Then, how will the referral system work? Sending the patient with only 
a referral slip is not a true referral. It is not followed appropriately. We need to discuss the issue of the 
referral system at national level. Health system researchers will manage it.”  
Deputy Director, DGFP  
STAKEHOLDER SURVEY FINDINGS IN BANGLADESH 
As part of the landscape analysis, researchers designed and distributed an online survey to key international 
and national organizations to assess the breadth and depth of MNH programs, key funders of MNH projects, 
and the primary topic areas each program is targeting. Eighteen responses were captured.  
Current maternal and newborn health projects 
The most frequently reported focuses of current MNH programs are ANC (n=16), FP (14), PNC (14), newborn 
care (13), PE/E (13), quality of care (13), EmOC (11), maternal mortality death reviews (10), and postpartum 
hemorrhage (PPH) (9). These MNH programs are throughout the country, with more efforts concentrated in the 
districts of Sylhet (n=10), Chittagong (6), Dhaka (6), Habigonj (6), Khulna (6), Barisal (5), and Cox’s Bazar (5).  
The online survey revealed MNH projects implemented at all health system levels, with most organizations 
reporting working at multiple levels: with 11 at the community level, 10 at district level, 10 at UH&FWCs or rural 
dispensaries, nine at UHCs providing Comprehensive Emergency Obstetric and Neonatal Care (CEmONC), and 
six at UHCs providing Basic EmONC at community clinics. These projects reported that their work has the most 





The most often reported funding organizations were the Government of Bangladesh, Dhaka South City 
Corporation, and Urban Primary Health Care Services Delivery Project. International donors include USAID, the 
Bill and Melinda Gates Foundation (BMGF) and Department for International Development (DFID), Canadian 
International Development Agency (CIDA), UNICEF, UNFPA, Japan International Cooperation Agency (JICA), 
AusAID, Swedish International Development Cooperation Agency (SIDA), WHO, and GlaxoSmithKline.  
NATIONAL STAKEHOLDERS VIEWS  
In collaboration with Directorate General of Family Planning (DGFP), MoHFW and OGSB, Population Council 
organized a National Stakeholders’ Meeting on November 4, 2015 to disseminate findings of the Landscape 
Analysis and gather recommendations for scaling up PE/E intervention. The meeting was attended by a large 
number of stakeholders and partners, representatives of MoH&FW, USAID, other donors, including national and 
district MoH&FW managers in Dhaka. The specific objectives of the meeting were to:  
• Share the findings of the Landscaping Analysis,  
• Share community experiences of other stakeholders on PE/E programs;  
• Inform and sensitize the four district managers; and 
• Hear other organizations’ PE/E experiences in their communities and PHC facilities (Save the Children, 
LAMB-Community Health & Development Program, and CARE Bangladesh).  
During the discussion session challenges and gaps were identified by the participants and recommendations 
suggested for implementation.  
Gaps and challenges identified 
• Poor ANC coverage due to lack of community awareness; 
• Poor and low identification of PE/E by PHC service providers (nurses, FWVs, SACMO, midwives, paramedics) 
during ANC consultations due to lack of knowledge, skills, confidence, logistical support, training, and 
reluctance by service providers; 
• Poor availability of necessary supplies (BP machine, test tubes, dipsticks, MgSO4, calcium gluconate, etc.) 
at PHC centers and unreliable supply of MgSO4 within government system; 
• Non-availability of single loading dose MgSO4 (IM injection); 
• Low use of MgSO4 due to lack of detection of PE/E; 
• Service providers and program managers are unaware of government policy on loading dose of MgSO4 by 
PHC service providers; 
• Gaps for PE/E prevention and management at the secondary level; and 
• Poor and non-functional referral system.  
Recommendations 
Policy  
• Ensure strong technical and supportive supervision of PHC service providers; 
• Work with pharmaceutical companies for production of an ampoule of MgSO4 for an intramuscular loading 
dose; 
• Circulate government policy documents and standard operation procedure (SOP) for PE/E management to 




Health system  
• Provide hands-on quality training to PHC providers with a standard duration for building confidence and 
skills to detect, manage, and refer women with PE/E;  
• Ensure quality ANC consultation and provide mentorship from an experienced providers in districts and 
sub-districts;  
• Ensure availability of calcium gluconate at public facilities; 
• Review and revise the training curricula for nurses, FWVs, midwives, and other paramedics;  
• Identify specific referral facilities in each area and support readiness of those facilities and let people know 
where it is located.  
Community  
• Improve community awareness by enlisting public representatives, religious leaders, Imams, and priests; 
• Use of information communication technologies (ICT) and behavior change communication (BCC) materials 







Secondary and PHC facilities are included in this study. To assess the capacity of the facilities and service 
providers to provide PE/E services, researchers used various methods: observation of client and provider 
interactions, ANC exit client interviews, facility inventories, and service provider interviews, with different 
categories of providers working in ANC, maternal and labor wards, or PHC center. This section reports on findings 
from the facilities and service providers, particularly those that are required for PE/E service provision including: 
required infrastructure for providing MNH services, facility capacity to perform certain activities for PE/E services, 
MNH logistics, ANC, PNC and delivery service provision, PE/E service provision, and service providers’ 
knowledge, attitudes, and practices. The operational definitions which are used for the study purposes are 
presented in Box 2.  
 
BOX 2: Definitions  
Chronic hypertension in pregnancy is defined as BP recording of ≥160/100mmHg during pregnancy 
with no proteinuria and not resolving postpartum.  
Pre-eclampsia is the development of hypertension (≥140/90) and significant proteinuria for the first 
time after 20 weeks of gestation of a woman who previously had normal blood pressure.  
- Hypertension is defined as blood pressure (BP) measurement of ≥140mmHg systolic and/or BP of 
≥90mmHg diastolic (either one) measured on two consecutive occasions four hours apart.  
- Significant proteinuria is defined as protein of 0. 3g in 24 hours collection of urine, or a urine protein 
estimation that is ≥ 2++ using dipsticks.  
Severe pre-eclampsia is:  
a) Diastolic blood pressure is ≥110 mmHg and/or systolic ≥160mmHg after two measurements, four 
hours apart + albumin in urine;  
OR 
b) Diastolic blood pressure is 90-109 mmHg or systolic ≥160mmHg after two measurements four 
hours apart + albumin in urine + severe headache, and/or blurred vision, and/or pain in upper 
abdomen.  
SPE is associated with symptoms and clinical manifestations such as severe headache, changes in 
vision (including temporary loss of vision/blurred vision, light sensitivity, seeing spots), upper abdominal 
pain (usually under ribs on the right side, nausea/vomiting, dizziness, and decreased urine output.  
Eclampsia is defined as pregnancy induced high blood pressure (140/90 mmHg or greater), excess 
protein in urine (Albuminuria) and convulsions after 20 weeks of pregnancy with the absence of any 






GUIDELINES AND PROTOCOL FOR PE/E DIAGNOSIS  
AND MANAGEMENT  
Available written guidelines or protocol for diagnosing and managing PE/E are pre-requisites for successful 
treatment women with PE/E. Respondents were asked about the existence of any written guidelines or protocols 
for diagnosing and managing PE/E and administering MgSO4. Table 4 shows that all DHs reported availability of 
guidelines or protocols but only 50 percent of MCWCs and 36 percent of UHCs have the same. As expected, no 
H&FWC have any guidelines or protocols for diagnosing and managing PE/E available. We found a similar 
situation concerning guidelines or protocol on the administration of MgSO4; no written guidelines or protocol was 
found in any of the centers.  
TABLE 4   Availability of guidelines and protocols for diagnosis and management 
 Type of Facility (number)  
Availability of guidelines or protocol DH MCWC UHC H&FWC Total 
Protocols or guidelines for diagnosing PE 4 2 4 0 10 
Protocols or guidelines for managing PE 4 2 4 0 10 
Protocols or guidelines for diagnosing eclampsia 4 2 4 0 10 
Protocols or guidelines for managing eclampsia 4 2 4 0 10 
Protocol or guidelines for administering MgSO4 4 1 2 0 7 
N 4 4 11 115 134 
 
INFRASTUCTURRE AND LOGISTICS 
Availability and function of infrastructure and logistics  
Facility inventories in each of the 134 centers in four districts assessed the center for provision of MNH services. 
Inventory exploration included availability of various registers for MNH service information; availability and 
functionality of the facility structure for MNH services; facilities for ANC, delivery and PNC services; availability 
and use of PE/E commodities and logistics and existence of referral mechanisms.  
All secondary facilities (DH, MCWC and UHC) have registers for documenting ANC, PNC, delivery referral, 
admission, and operating theater information; they do not, however, have death registers. PHC centers 
(UH&FWC) do not have MNH registers, they only have ANC and/or referral registers. Only 22 percent of UH&FWCs 
have maternity admission registers and 20 percent have maternal death registers (Table 5).  
Facility availability and function for providing MNH services 
is mixed. While most secondary facilities have functional 
facilities for clean water supply, 24 hour power, adequate 
lighting, functional autoclave or sterilization instruments, 
infection prevention buckets, chlorine solution, functional 
delivery beds, and postnatal wards with beds and operating 
theater, PHC facilities lack essential infrastructure and 
supplies for quality MNH services: Only 59 percent of 
UH&FWCs have facilities for clean water supply and 39 
percent have 24 hour power (Table 5).  
 
Primary Health Care facilities 
(H&FWCs) lack essential 
infrastructure and supplies  





TABLE 5    Distribution of facilities by availability and functionality of MNH indicators 
Availability of MNH registers 
Type of Facility (%)  
DH MCWC UHC H&FWC Total 
ANC and referrals register 100 100 100 100 100 
Delivery register 100 100 100 93 94 
PNC register 100 100 91 95 95 
Maternity admission register 100 100 100 22 33 
Operating theatre register 100 100 100 32 42 
Maternal deaths register 100 50 82 20 28 
Availability and functionality of facility structure for MNH services 
Clean water supply for 24 hours 100 100 100 59 65 
24 hour power supply 75 100 91 39 46 
Adequate lighting 100 100 100 51 58 
Functional autoclave/sterilization instruments 100 100 91 65 69 
Infection prevention buckets 100 100 100 90 92 
Chlorine solution for processing equipment 100 100 91 80 82 
Functioning delivery bed 100 100 100 78 81 
Postnatal ward with beds 100 100 100 0 14 
Operation theater 100 100 100 32 42 
N 4 4 11 115 134 
 
ANC, delivery, and PNC service provision  
A number of questions were asked and checked to assess the service provision for ANC, delivery, and PNC. 
Findings suggest that all facilities, including PHC facilities, provide ANC, delivery and PNC services. However, the 
number of staff working at the ANC or delivery unit varies significantly between PHC and secondary facilities. The 
H&FWCs run with one or two staff while secondary facilities have two or more staff. While all of the secondary 
facilities admit patients for delivery only 18 out of 115 (16%) H&FWCs do the same. Almost all of the secondary 
facilities serve four or more ANC clients per day, while about 50 percent of the H&FWCs serve fewer clients daily.  
Pre-eclampsia and eclampsia service provision  
Informants from all facilities were asked if any women presented with PE/E during ANC, delivery, or post-natally, 
and how many they had seen within the previous six months (Table 6, page 23). Providers from all of the 
secondary facilities reported detecting pre-eclampsia clients during ANC service provision, 64 percent of UHCs 
reported doing so, and 30 percent of UH&FWCs (30%) detect PE patients during ANC service provision. Detection 






TABLE 6   Pre-eclampsia and eclampsia service provision 
    Type of Facility (number)   
Pre-eclampsia and eclampsia Response  DH MCWC UHC H&FWC Total 
Saw client with PE during ANC visit Yes 4 4 7 34 49 
N   4 4 11 115 134 
No. of PE patients seen in the last six months None 0 1 1 10 12 
    1 - 2 0 0 2 19 21 
  >2 4 3 4 5 16 
N   4 4 7 34 49 
Saw clients with eclampsia during ANC visit Yes 3 1 4 5 13 
N   4 4 11 115 134 
No. of clients seen in the last six months   1 1 1 1 4 7 
  >1 2 0 3 1 6 
N   3 1 4 5 13 
Admitted PE patients in the labor ward Yes 4 1 5 0 10 
N   4 4 11 115 134 
No. of PE patients admitted in the last six months Up to 5 2 0 4  - 6 
  >5 2 1 1  - 4 
N   4 1 5   10 
Admitted eclampsia patients in the labor ward Yes 2 1 1 0 4 
N   4 4 11 115 134 
No. of eclampsia patients admitted in the last six 
months 13 1 1 1 - 3 
  >3 1 0 0  - 1 
N   2 1 1 - 4 
Saw PE patients in the facility during PNC visit Yes 3 1 1 9 14 
N   4 4 11 115 134 
PE patients seen in the last six months   1 0 1 0 8 9 
  >1 3 0 1 1 5 
N   3 1 1 9 14 
Saw eclampsia patients in facility during PNC visit Yes 4 0 0 1 5 
N   4 4 11 115 134 
Eclampsia patients seen in the last six months   1 3 0 0 1 4 
  >1 1  -  - 0 1 






Availability of PE/E equipment and commodities, and their uses 
It is essential that certain equipment and commodities needed to provide PE/E services are available at the 
facilities. Table 7 shows that there is a lack of essential equipment and commodities in all H&FWCs as well as 
some of the secondary facilities. MgSO4 is found in only in four secondary facilities and none of the H&FWCs. 
Calcium gluconate for managing MgSO4 toxicity is found in only one secondary facility and no PHCs (Table 7, 
page 25).  
Only four of 20 secondary facilities reported 
use of MgSO4 regularly while another seven 
reported use of MgSO4 occasionally. It is 
important to note that three out of four 
MCWCs (75%) and five out of 11 UHCs (45%) 
(secondary facilities) never used MgSO4 at 
the facility. Those who use MgSO4 mentioned 
using various concentrations of MgSO4. 
Some said 20% solution, some said four 
percent water/volume (w/v), some said 50% solution, and some informants could not name the concentration 
they used. Those who use MgSO4 use both intramuscular (IM) and intravenous (IV) routes.  
How facilities obtain MgSO4 
Out of 11 facilities that use MgSO4, six facilities (55%) either get it from central level as a regular supply or 
purchase it from local market and the remaining five facilities (45%) reported that clients purchase it from the 
market when there is a need (Table 7).  
Prescribing anti-hypertensive drugs 
Out of 286 service providers interviewed, almost 50 percent prescribe antihypertensive drugs (Table 7). Further 
analysis suggest that about 82 percent of physicians prescribe antihypertensive drug, as they are allowed to, 
and 41 percent of other service providers prescribe antihypertensive dugs, although they are not allowed to 
prescribe them.  
  
MgSO4 is found in only in four secondary 
facilities and no PHCs. Calcium 
gluconate for managing MgSO4 toxicity 
is found in only one secondary facility 





TABLE 7   Availability of functional PE/E equipment and commodities, and use 
 Type of Facility (number)  
Equipment and commodities DH MCWC UHC H&FWC Total 
Stethoscope 4 4 11 101 120 
Sphygmomanometer 4 4 11 95 114 
Clean container/test tube for urine test 4 2 10 28 44 
Patella hammer 3 3 8 20 34 
MgSO4 1 1 2 0 4 
Calcium gluconate  0 1 0 0 1 
Use of MgSO4 to treat PE/E      
Magnesium sulphate is always used 1 1 2 0 4 
Magnesium sulphate is sometimes used  3 0 4 0 7 
Magnesium sulphate is never used 0 3 5 115 123 
N 4 4 11 115 134 
Concentration of MgSO4 used      
20% solution 0 0 2 0 2 
4% w/v (Nalepsin) 1 1 2 0 4 
50% solution 2 0 0 0 2 
Do not know 1 0 2 0 3 
Route use for administration      
IV 0 1 3 - 4 
IM 4 0 0 - 4 
Both 0 0 3 - 3 
Supply of MgSO4      
Regular supply from central level 1 0 3 0 4 
Local purchase 1 1 0 0 2 
Client purchases it from the market  2 0 3 0 5 
N 4 1 6 - 11 
Prescribe antihypertensive drug      
Yes 12 12 46 84 135 
No 4 0 22 106 151 







Facility capacity for parental routes, caesarian section, blood transfusion, 
and neonatal resuscitation (EmONC) 
Certain skills are essential for PE/E patient management. Informants from facilities were asked if their service 
providers had the necessary skills for providing Emergency Obstetric and Neonatal Care (EmONC), which include 
the capacity to administer parental antibiotics, oxytocin, and anticonvulsants, make blood transfusions, perform 
caesarian sections and neonatal resuscitation, and whether or not they had occurred in the last three months. 
Findings suggest that not all these elements are available in all secondary facilities and many did not occur in 
the last three months. PHC service providers have the lowest capacity for treating PE/E patients. Service 
providers from two out of four DHs, two out of four MCWCs, three out of 11 UHCs, and one out of 115 UH&FWCs 
have the capacity to administer intravenous MgSO4, and all of them have done so in the last three months.  
Availability of regular and emergency response materials for PE/E services 
All facility informants were asked to report if they have certain regular and emergency response materials in the 
facility particularly related to the provision of PE/E services. Almost all secondary facilities reported having all 
regular and emergency response materials. PHCs, however, are not designed to provide emergency care, though 
some of these facilities have the materials in variable quantities and the availability is very low. Only 13 centers 
have 20 milliliter syringes, no facilities had 6mg betamethasone/dexamethasone for premature respiratory 
distress syndrome (PRDS) and 15 PHCs had none of the regular and emergency response materials. 
Interestingly, 61 percent and 86 percent of PHCs had Misoprostol for PPH prevention and neonatal resuscitation 
kits for neonatal resuscitation, respectively (Table 8).  
TABLE 8   Facility materials for regular and emergency responses 
 Type of Facility (number)  
Regular and emergency response materials DH MCWC UHC FWC Total 
Regular materials      
Self-retaining catheter 4 4 9 8 25 
Urine bag 4 4 11 4 23 
20 milliliter syringe 1 4 5 3 13 
Xylocaine/LA 3 4 11 16 34 
Normal saline(IV) 3 4 10 41 58 
IV equipment 4 4 11 20 39 
Syringes and needles 4 4 11 92 111 
Saline Stand 4 4 11 53 72 
Don't have anything 0 0 0 15 15 
Emergency response materials      
Oxygen and adult masks 4 4 11 0 19 
6 mg Betamethasone/dexamethasone 0 0 0 0 0 
Misoprostol 3 4 10 70 87 
Neonatal resuscitation kit 4 4 11 99 118 
Ambulance 4 4 11 0 19 




SERVICE PROVIDERS’ KNOWLEDGE, ATTITUDES, PRACTICES 
Two-hundred eighty-nine (289) service providers from 134 facilities were interviewed face-to-face to assess their 
knowledge, attitudes and practices regarding maternal health; particularly PE/E. Among the service providers, 
79 were doctors (including those who were working in the MCH Unit) and 210 were other service providers 
(nurse, FWV, SACMO, MA).  
Service provider awareness of PE/E policy and protocol for community level 
MgSO4 loading dose  
Service providers are mostly unaware of the policy on PE/E. As expected, they are also not aware about the 
protocol or guidelines for administering the loading dose of MgSO4 to prevent and manage PE/E within the 
community. Only about 27 percent of doctors and three percent of other service providers were aware of any 
guidelines on the use of prophylactic drugs for PE/E prevention.  
Service provider knowledge and practice for PE prevention  
Researchers assessed health care providers’ knowledge of proven P/E risk factors, including history of 
hypertension, diabetes, bad obstetrics, extreme maternal age (<18 or ≥ 30 years), and others. Only 1.87 percent 
of providers observed (n=268) in secondary and PHC facilities looked for PE risk factors during ANC 
consultations, while four percent advised women of symptoms for impending eclampsia, and eight percent of 
secondary facility providers and one percent from PHC facilities described pre-eclampsia detection. The following 
definitions were used to measure provider awareness for the prevention of eclampsia: 
Assessing the risk of PE: Asked about client’s age, number of current pregnancy (gravida), measured weight, 
checked edema, history of hypertension and history of diabetes.  
Detecting PE: Measured client’s blood pressure and tested urine for protein/albumin.  
Advising on the symptoms of impending eclampsia: High blood pressure, generalized edema, proteinuria, 
severe headache, blurring of vision and upper abdominal pain.  
Service provider knowledge of drug use for PE prevention  
Precursors to PE/E can be identified and managed to prevent escalation. Researchers investigated service 
provider knowledge on prophylactic drugs such as calcium supplements or low dose aspirin and found only six 
percent of doctors and no other service providers aware of the use of aspirin or calcium supplements for 
prevention of pre-eclampsia (Figure 2). 

























No providers interviewed mentioned calcium supplements as a prophylaxis. About 20% doctors and 3% other 
service providers mentioned other drugs as prophylaxis or said that they did not know, which indicates confusion 
around preventive drugs. These providers mentioned Amlodipine, Methyldopa, Nifedipine (BP lowering drugs) 
and Phenobarbitone as prophylactic drugs to prevent PE/E in pregnancy.  
Table 9 presents the use and relationship of aspirin prophylaxis and anti-hypertensive drugs with other variables. 
Doctors and providers in secondary facilities were significantly more likely to associate the use of aspirin 
prophylaxis among pregnant women at risk of developing PE. Duration of experience in the same unit and 
previous training on maternal health, family planning (FP), or child health have no effect on whether a provider 
would give aspirin prophylaxis for high risk women.  
TABLE 9:    Use and relationship of aspirin prophylaxis and anti-hypertensive drugs 
with other variables 
Independent variable 
 Use aspirin among women 
who are at risk of 
developing PE 
Use anti-hypertensive 
drugs with pregnant 
women who have high BP 
N=289 
 % Correct 
response p-value 
% Correct 
response p-value N 
Type of provider        





Other service providers  0. 00 40. 95 210 
Type of facility        





Primary  0. 52 43. 46 191 
Duration work in current unit/ward (years)    





>1-5 years  6. 38 48. 94 47 
>5 years  6. 28 51. 21 207 
Any training on maternal health, FP or child health care    





No   8. 97 55. 86 145 
*Fisher’s exact test 
Similar findings were also observed regarding use of anti-hypertensive drugs among pregnant women who have 
high blood pressure. Doctors and providers in secondary facilities (p <0. 000) and more years of experience 
(p<0. 057) are more likely to be associated with the use of anti-hypertensive drugs with pregnant women who 
have high blood pressure.  
Service provider knowledge and capacity to detect hypertensive disorders 
in pregnancy 
Eighty-four percent of doctors and 79 percent of other service providers were able to correctly define 
hypertension as systolic blood pressure of ≥140 mmHg and/or diastolic blood pressure of ≥90 mmHg (either 
one), although 17 percent of doctors and 22 percent of the service providers are confused about the definition 
of hypertension.  
In addition to the definition of hypertension, service providers’ knowledge on hypertensive disorders in pregnancy 
was assessed by three hypothetical situations on hypertensive disorders in pregnancy. These three situations 
were presented to determine the best diagnosis that fits the situations. Situation A involved “A pregnant woman 




of 2++, what would be the diagnosis? Situation B involved “A pregnant woman was seen in the antenatal clinic 
at 12 weeks of gestation with blood pressure 160/100mmHg with no proteinuria, what would be the diagnosis?” 
Situation C involved “A pregnant woman was found to have developed hypertension and significant proteinuria 
at 30 weeks of gestation. 1 week later, her partner brought her to the clinic with complaints of convulsion, what 
would be the diagnosis?” The service provider’s correct knowledge on diagnosis is presented in Figure 3.  
FIGURE 3 Correct responses from service providers on hypothetical questions  




All service providers were requested to identify signs and symptoms of pre-eclampsia, severe pre-eclampsia and 
eclampsia. Researchers found that doctors had good knowledge and other service providers had reasonably 
good knowledge on the signs/symptoms of PE, severe PE and eclampsia. Findings suggest that while both 
doctors and other cadres mentioned a number of important signs/symptoms of PE, severe PE and eclampsia, 
they also mentioned some less important and un-important signs/symptoms. For example, for pre-eclampsia 
they mentioned weight gain and bleeding. 
Table 10 describes service provider knowledge and ability to detect and classify hypertensive disorders in 
pregnancy (provided three hypothetical situations Situation A, Situation B, Situation C) were analyzed against 
the same independent variables above. Table 10 (page 30) shows that there is no direct correlation between 
correct clinical diagnosis of chronic hypertension in pregnancy and eclampsia with type of provider, type of 
facility, duration of work in the same unit or ward and received any training on maternal health, FP, or child 
health care. However, correct diagnosis of severe PE was significantly associated with type of provider (p<0. 











































TABLE 10   Provider knowledge and ability to detect hypertensive disorders  
in pregnancy 
 Chronic hypertension 







response p-value n 
Type of provider         




100. 0  79 
Other service 
providers 77. 62 50. 00 96. 19 0. 377 210 
Type of facility         







Primary 79. 52 46. 60 95. 81 191 
Duration of work in the current unit/ward (years) 







>1-5 years 82. 98 57. 45 97. 87 47 
>5 years 79. 23 54. 59 97. 10 207 
Any training on maternal health, FP or child health care 







No  81. 38 58. 62 96. 55 145 
 
Knowledge and practices of service providers to manage PE/SPE/E 
Service providers must have the knowledge and skills for appropriate PE/E management. They must know what 
anti-hypertensive drugs should be used and when to initiate (at what blood pressure). They should also know 
what anticonvulsants to administer, such as MgSO4, and how (and how to monitor, identify and administer 
calcium gluconate for any MgSO4 toxicity) if required. In this study, researchers asked service providers about 
commonly used anti-hypertensive drug for managing mild to moderate hypertension, and severe hypertension 
in pregnancy. It was also explored at what levels of blood pressure these drugs should be administered.  
The recommended first choice of drug is Labetalol. Methyldopa or Nifedipine is the second choice of drug for 
mild to moderate hypertension in pregnancy6. Hydralazine (a peripheral arterial vasodilator) is the drug of choice 
for severe hypertension in pregnancy8. As Labetalol is not widely available in Bangladesh and expensive, 
Nifedipine and Methyldopa are often the drugs of choice. Only about 77% doctors and 19% other service 
providers mentioned Methyldopa or Nifedipine as the drugs of choice for managing mild to moderate 
hypertension in pregnancy. For severe hypertension, only 9% doctors and none of the other service providers 
can mentioned Hydralazine as the drug of choice.  
Anti-hypertensives should be initiated for controlling mild to moderate blood pressure at a level of 
≥150/100mmHg in pregnancy8. The use of a vasodilator to lower blood pressure rapidly to a safer level 
(<110mmHg) is also recommended8. Table 11 (page 31) shows poor provider knowledge for introducing anti-
hypertensives in pregnant women with hypertensive disorders. Only 53 percent of doctors and 39 percent of 
other service providers correctly knew when anti-hypertensive drugs should be initiated (≥140/90 to 159/109). 
                                                          
 
 




For severe hypertension, only 19 percent of doctors and nine percent of other service providers correctly knew 
when Hydralazine should be initiated (≥160/110).  
There is no correlation between the type of facility and which providers know when to start anti-hypertensives. 
Knowledge gaps persisted across providers at primary and secondary facilities.  
TABLE 11    Service provider knowledge on when to initiate anti-hypertensive drugs 
for mild to moderate and severe hypertension in pregnancy 
Independent variable 
Mild to moderate 




response p-value n 
Type of provider 





Other service providers 38. 57 8. 57 210 
Type of facility 





Primary 37. 17 8. 90 191 
Years working in present unit/ward 





>1-5 years 44. 68 12. 77 47 
>5  years 39. 61 9. 66 207 
Any training on maternal health, FP or child health care 





No 46. 21 12. 41 145 
*Fisher’s exact test 
Service provider knowledge, attitudes and practice on MgSO4 
Controlling impending convulsions in cases of severe PE, and convulsions from eclampsia, with anticonvulsants 
is a life-saving intervention for both mothers and babies. Evidence recommends MgSO4 as the ‘gold standard’ 
for preventing and treating severe PE/E convulsions. Administering MgSO4 intramuscularly (Pritchard regimen7) 
is preferred and is the most utilized regimen, whereby 14 grams of MgSO4 is administered as a loading dose, 
followed by five grams intramuscularly into alternate buttocks, every four hours, for maintenance.  
Service providers were asked to explicate the loading dose of MgSO4 (Pritchard regimen) and maintenance dose 
of MgSO4. Findings suggest that only 35 percent of doctors and one percent of other service providers correctly 
knew the loading of MgSO4 to be administered, and only 36 percent of doctors and one percent of other service 
providers correctly knew the maintenance dose of MgSO4 (Table 12, page 32).  
Table 12 shows that doctors providers working in secondary facilities and providers with longer experience are 
significantly more likely to know the total Pritchard regimen (loading dose and maintenance doses of MgS04). 
Previous exposure to any MCH training has no association with either of these two indicators.  
                                                          
 
 
7  The alternative regimen is the Zuspam regimen whereby MgSO4 is administered intravenously at a given rate using infusion pump. 
Because infusion pumps are generally not available in most developing countries, Bangladesh adopted the Pritchard regimen for all of 




TABLE 12    Service provider knowledge of total loading and maintenance doses  
of MgSO4 and their associations 
Independent variable 
 What is the total loading dose of MgS04? 
What is the 
maintenance dose of 
MgS04 in PE/E for 
intramuscular injection? 
N=289 
  % Correct 
response p-value 
% Correct 
response p-value n 
Type of provider        





Others service providers  1. 43 0. 48 210 
Type of facility        





Primary  2. 09 1. 05 191 
Duration of work at the same unit/ward    





>1-5 years  17. 02 19. 15 47 
>5 years  5. 80 5. 31 207 
Received any training on maternal health, FP or child health care    





No   15. 17 13. 79 145 
*Fisher’s exact test 
Although rare, toxicity of MgSO4 may occur. Calcium gluconate is the antidote for MgSO4 toxicity. All service 
providers were asked if they knew of any drug used to treat MgSO4 toxicity. Only 30 percent of doctors and less 
than one percent of other providers knew that calcium gluconate is the antidote for MgSO4 toxicity.  
The toxicity of MgSO4 may manifest as depressed respiratory rate, loss of tendon reflex, or decreased urine 
output, either in isolation or in any combination of all three. Only 48 percent of doctors and one percent of other 
service providers knew at least one sign or symptom of toxicity, while only 18 percent of doctors and one percent 
of other service providers knew all three signs or symptoms to monitor MgSO4 toxicity (Figure 4).  




























Table 13 shows that doctors, providers working in secondary facilities, providers with more  experience in the 
same unit, and previous exposure to any training on MCH training are significantly more likely to know how to 
monitor and treat MgSO4 toxicity. About four fifths of doctors, however, did not know how to monitor for toxicity, 
and about two thirds of the doctors did not know what drug is used to treat MgSO4 toxicity.  
TABLE 13  Service provider knowledge on monitoring for MgSO4 toxicity 
Independent variable 
Ways to monitor  
for MgS04 toxicity 
What drug treats 
MgS04 toxicity? N=289 
 % Correct response p-value 
% Correct 
response p-value n 
Type of provider 





Other service provider 0. 00 0. 48 210 
Type of facility 





Primary 0. 00 0. 52 191 
Years working in present unit/ward 





>1-5 years 4. 26 10. 64 47 
>5  years 1. 46 7. 25 207 
Any training on maternal health/FP/child health care 





No 7. 59 10. 34 145 
*Fisher’s exact test 
 
Service provider practice for MgSO4 
We asked service provides about their current practices regarding use of MgSO4, supply of MgSO4, availability of 
MgSO4 at the facility, alternative drug use to control seizures, and barriers to MgSO4 use. Only 37 percent of 
doctors and four percent of other service providers reported currently using MgSO4. Those who are using MgSO4 
mentioned supply conditions of MgSO4. Thirty-three percent of providers (31% of doctors and 38% of other 
service providers) reported sufficient supply, five percent overall reported inadequate supply (7% of doctors and 
none of the other service providers), and the remaining 62 percent of providers reported none.  
All service providers were asked to report whether MgSO4 is currently available at the facility. Only 11 percent of 
all service providers (33% of doctors and 3% of other service providers) reported availability of MgSO4 at the 
facility. The reasons for non-availability include no supply (59%), no training (15%), not allowed to administer the 
drug (10%), and 23 percent of providers reported that they do not know why it is not available.  
About 39 percent of doctors and four percent of other service providers reported use of alternative drugs for 
controlling convulsions with PE/E patients. Service providers use a number of alternative drugs instead of MgSO4 
to control seizures in PE/E patients. Among those who reported using alternative drugs, 58 percent of doctors 
and 63 percent of other service providers reported using an appropriate (though less safe and effective) 
alternative like diazepam to control convulsions in PE/E patients. Sixty-seven percent reported using anti-
hypertensive drugs to control convulsions.  
About 71 percent of doctors and 35 percent of other service providers mentioned some barriers to administering 
the loading dose of MgSO4 to SPE/E patients at the PHC level. Those barriers were lack of training (65%), lack 
of knowledge of side effects (25%), lack of equipment or supply (18%), need for doctor supervision (13%), fear 




Service provider views on facility readiness for providing PE/E services 
Service providers’ responses helped assess facility readiness for providing PE/E services. Findings suggest that 
94 percent of respondents from DHs, 50 percent from MCWCs, 77 percent from UHCs, and 10 percent from 
H&FWCs reported PE/E patients visit the facility. Researchers also asked service providers a number of related 
questions on facility readiness. Findings show that 81 percent of service providers from DHs reported that their 
facilities are ready with PE/E training and 50 percent of providers from MCWCs, 77 percent from UHCs and 10 
percent from H&FWCs reported the same. Fifty-six percent of service providers from DHs, 33 percent from 
MCWCs, 63 percent from UHCs, and nine percent from H&FWCs stated that MgSO4 is available at their facility.  
Service provider practices with ANC clients 
A total of 268 client and provider interactions (CPIs) were observed to assess the quality of service for clients. 
CPIs showed that service providers are capable of reasonably good service, except for providing BCC materials. 
These findings were not uniform for all facilities.  
Researchers observed service providers’ inquiries and history taking, performance, and discussion with clients. 
History taking seems weak among most providers in all facilities. Most providers inquire about the total number 
of pregnancies, date of last delivery, duration of gestation, and any current medication. When taking a client’s 
medical history, providers rarely ask about any history of hypertension or previous history of signs or symptoms 
of PE/E, and history of other diseases.  
Physical examination is not consistent among all service providers at all facilities. Although there were 
inconsistencies, most service providers checked weight, blood pressure, and edema, palpated the abdomen, 
checked for fetal movement, and listened to the fetal heart rate.  
Discussion with clients was poor: Only a few providers from secondary facilities and approximately one third from 
H&FWCs discussed birth planning with clients. In addition, 10 out of 20 service providers from DHs, six out of 
16 providers from MCWCs, 13 out of 22 providers from UHCs and 141 out of 210 providers from H&FWCs 
advised clients to return for a follow up visit in the event of any complications.  
CLIENT EXPERIENCES  
ANC exit client interviews after observations of CPIs assessed pregnant women’s perceptions of their care 
quality, and understanding of their services. Analysis of 268 ANC responses shows that clients attending MCWCs 
and H&FWCs received more ANC service components than other types of health facilities.  
TABLE 14   ANC services received on the day of visit 
ANC service component 
Types of Facility (n) Total 
(268) DH (20) MCWC (16) UHC (22) H&FWC (210) 
Measured weight 75% 75% 73% 86% 83% 
Checked blood pressure 60% 94% 77% 82% 81% 
Abdominal examination 25% 69% 77% 93% 85% 
Checked for anemia 15% 50% 77% 79% 73% 
Listened to baby’s heartbeat 20% 56% 64% 52% 51% 
Checked urine for protein and sugar 5% 0% 27% 6% 7% 
Told about the progress of pregnancy 80% 94% 77% 83% 83% 
Given chance to ask questions 80% 75% 86% 82% 82% 




Table 15 shows composite responses to the questions about the eight ANC components that should be provided 
during ANC consultation. Only two percent of clients received all nine ANC components at their current visit 
(weight, blood pressure, abdominal examination, check for anemia, infant heartbeat, urine check for protein and 
sugar, discussion about progress of your pregnancy, and chance to ask questions).  
Demographic characteristics (age, education, socio-economic status, religion) had no association with a client’s 
likelihood for receiving all nine ANC components during the visit or receiving all six services listed earlier during 
any ANC visit.  
TABLE 15   Required services and information during ANC consultation 
Independent variable 
 
Proportion of clients  
receiving all 8 ANC 
components during this 
visit 
Proportion of clients  
receiving all 6 services 
listed above during any 
ANC visit 
 n Yes (%) p-value Yes (%) p-value 
Age 




≥25 117 2. 56 1. 71 
Education 




Primary 78 3. 85 0. 00 
Secondary 136 0. 74 5. 88 
Higher 33 0. 00 6. 06 
Socio-economic Status 
Low 93 1. 08 
0. 331* 
3. 23 
0. 265* Middle 93 3. 23 2. 15 
High 82 0. 00 7. 32 
Religion 




Hindu 22 4. 55 9. 09 
Total 268 1. 49  4. 10  
*Fisher’s exact test 
ANC client knowledge on danger sings during pregnancy 
The exit interviews showed that ANC clients have very poor knowledge of the danger signs during pregnancy. 
Only about one sixth to one fourth of clients had some knowledge on aspects of danger signs. Client knowledge 
on PE/E is particularly poor─only four percent mentioned high blood pressure and 13 percent reported 
convulsions as danger signs during pregnancy─indicating the need for strengthening educational efforts.  
Perception of quality of care at this ANC visit 
Clients interviewed received care during this visit from FWVs (84%), doctors (12%), nurses (10%), while less than 
10 percent received services from a SACMO, CSBA, or MA. At a DH, MCWC, or UHC primarily doctors, nurses, or 
FWVs provided services, while at H&FWCs services were provided mainly by FWVs, SACMOs, CSBAs, or MAs.  
To assess ANC clients’ perceptions and satisfaction with their current visit, researchers asked about their waits 
for services, time spent with providers, and satisfaction with their services. Satisfaction was indirectly measured 
by asking if they would recommend that center to a friend for ANC care. Table 16 (page 36) shows that most 
ANC clients thought the waiting time and time spent with service provider reasonable. Most ANC clients were 




TABLE 16   Waits, time with providers, satisfaction  
  
Type of Facility (n) 
Total 





Waiting before being seen  
by the service provider (minutes) 
<15  50% 44% 54% 63% 60% 
15-29 30% 6% 27% 24% 23% 
>29 20% 50% 18% 13% 16% 
Perception of waiting time 
Too long 25% 44% 18% 14% 17% 
Reasonable 65% 31% 68% 58% 58% 
Too short 10% 25% 14% 28% 25% 
Time spent with the health care 
provider (minutes) 
<6 15% 6% 9% 12% 12% 
6-10 20% 12% 36% 43% 39% 
11-15 25% 31% 39% 20% 22% 
16-30 40% 25% 23% 23% 24% 
>30 0% 25% 0% 2% 3% 
Perception about time spent  
with the service provider 
Too long 10% 19% 0% 4% 5% 
Reasonable 45% 50% 82% 67% 65% 
Too short 45% 31% 18% 29% 29% 
Quality of services you received 
today 
Satisfied 70% 56% 77% 57% 60% 
Somewhat 
satisfied 10% 37% 18% 39% 35% 
Not satisfied 
at all 20% 6% 4% 3% 5% 
Would recommend a friend to come 
to this facility for ANC 
Yes 85% 75% 95% 94% 92% 







Community perceptions, beliefs and experiences 
Community perspectives of pre-eclampsia and eclampsia were sought in male and female focus group 
discussions (FGDs) and in-depth interviews (IDIs) with PE/E survivors for assessing community PE/E awareness, 
beliefs, and experiences, and the strategies for seeking care.  
Despite some similarities, major disparities of perceptions and beliefs exist among female and male informants 
about the serious problems women suffer during and after delivery. Most female participants reported excessive 
bleeding, convulsion, anemia, abdominal pain, physical weakness, malnutrition, retained placenta, ruptured 
uterus, and fetal presentation other than head as the most serious problems during pregnancy and immediately 
after childbirth. Most male informants reported anemia, physical weakness, leucorrhea (discharge), loss of 
appetite, headache, edema, retained placenta, and bleeding from the vagina as the most serious problems 
during pregnancy and immediately after childbirth. Almost all informants, regardless of district, mentioned 
anemia, edema, physical weakness, retained placenta, and vaginal bleeding as the most serious problems or 
complications women suffer during pregnancy and immediately after childbirth.  
When asked to list three major problems or complications during or after delivery, the most common responses 
from female informants were physical weakness, breech presentation, and bleeding before and after delivery. 
The most common responses from male participants were physical weakness, retained placenta, and vaginal 
bleeding. Informants consider pregnancy and its related problems to be natural and believe they heal over time. 
In addition, men consider these complications a woman’s problem:  
“The mothers of our community think these are general problems during pregnancy and delivery and 
they also passed through these. So, they don’t give much importance on the problems, rather suggest 
some spiritual and common sense remedies.”                                                                           Female, FGD 
On the other hand, one male informant said:  
“These are women’s problems during pregnancy and after delivery. My mother also passed through 
these. So, I don’t want to interfere with women’s problems and step in. My mother and grandmother 
might be the right persons to decide.”                                                                                              Male, FGD 
Health seeking behaviors for pregnancy problems or complications follow a pattern. Most men and women stated 
that at first the mother-in-law or husband takes the pregnant women to the Imam or kobiraj, a traditional or 
spiritual healer, and then to a village doctor. If the condition does not improve, they take her to a hospital. They 
believe “holy water,” herbs, exorcism, and charmed amulets can improve conditions. If a pregnant woman has 
a convulsion, community people believe she was caught by “the evil eye.” 
“My husband intends to take [me] to the hospital but mothers-in-law said that the nowadays daughters 
and daughters-in-law don’t have faith in Allah. They think that when they gave birth they did not go to 
the doctor or hospital, so they don’t want to take them to the hospital. But, they take the women to the 
doctor when it is too late and mother and child condition become serious. ”                          Female, FGD 
The influence of mothers-in-law and husbands, financial solvency, perceptions about poor quality of care at 
hospitals, and lack of transportation negatively affect the health seeking behaviors of women suffering from 
PE/E. Mothers-in-law or husbands make the decision to go a hospital. Most men and women mentioned that 
women do not seek care at facilities because of lack of money, lack of transportation, distance to hospital, lack 
of proper care at a hospital, lack of qualified doctors, and their mothers-in-laws’ strictures. Both pregnant women 
and their husbands prefer to go to a health facility if a woman suffers from high blood pressure or convulsions. 
Economically solvent couples attend private clinics, and those who cannot afford them go to “kabiraj” (traditional 
or spiritual healers) or the village doctor. 
“We go to the village doctors or Kabiraj [traditional or spiritual healers] seeking health services because 
of finances and lack of good treatment in the government hospital. There is no good doctor in our 




Suggestions from both male and female FGD informants on improving the care of pregnant women with PE/E 
include regular health worker visits in communities, meeting with husbands and wives together, and meeting 
with mothers-in-law or older people, sessions with qualified doctors in the community for pregnant women, and 
regular ANC check ups, among others.  
EXPERIENCES OF ECLAMPSIA SURVIVORS  
To assess the knowledge, attitudes, views, and experiences of eclampsia and pre-eclampsia among survivors of 
the condition, 22 survivors were interviewed about their antenatal care including their PE/E education and 
screening, the accessibility of essential services and commodities, and their strategies for care during their PE/E 
episodes. Informants, who had successfully delivered a child and were in stable condition, were purposively 
selected at a tertiary care hospital, following the hospital’s ethical procedures. Sixteen questions were posed.   
Socio-demographic characteristics 
Survivors were mostly 18 to 20 years old (n=13), between 21 to 25 (n=7), with only one 35 years old. Half (11) 
reported becoming pregnant between 18 and 20 years of age, while five became pregnant when they were 
younger than 18. About one third were illiterate, while the remaining two thirds had some education, either 
primary (n=4) or secondary or higher (19). About two thirds of informants (14) had one child, and the remaining 
eight had more than one.  
Availability of health facilities in communities 
Half (11) of the informants reported only needing 10 to 20 minutes to reach the nearest facility, while half 
required 30 minutes to an hour. Due to perceived unavailability of doctors and other commodities at public 
hospitals, most informants preferred services from private facilities, which are both nearby and perceived to 
have available staffs.  
Antenatal care quality 
The quality of ANC care reported by eclampsia survivors was inconsistent at best. Although 15 survivors received 
ANC, only 11 had their blood pressures measured. Four survivors reported normal blood pressure, while four 
had elevated readings. Urine tests were done in only four cases. Most respondents reported that their service 
providers advised them to eat nutritious food, prescribed medicines (calcium and iron), and advised them to rest 
and work less.  
Health seeking behaviors 
Many health problems in pregnant women can be prevented, detected, and treated during ANC visits with trained 
health workers. WHO recommends a minimum of four ANC visits, with tetanus toxoid vaccination, infection 
screening and treatment, and identification of warning signs. Among the 22 survivors, four informants received 
only one ANC check up at 32 weeks of gestation, four survivors received two to three ANC check ups, and seven 
survivors had five or more ANC check ups during their most recent pregnancy. Six survivors did not receive any 
ANC during their pregnancy, did not hear about it, or believed that pregnancy is normal and natural and ignored 
ANC check ups. Most remaining survivors went to clinics between eight and 12 weeks of gestation to confirm 
their pregnancy. Among six of the survivors, four had a sonogram to determine the infant’s sex. Three reported 
visiting the doctor because of complications such as convulsions, bleeding, and chest pain followed by 
convulsions. Almost all those who attended ANC reported that service providers did not give them any 
information on possible pregnancy problems or danger signs, and did not explain the significance of high blood 





Problems prior to convulsions 
Most eclampsia survivors said they did not notice any serious health problems, or they ignored them prior to 
their convulsions. Some survivors reported tolerable headaches, blurred vision, edema, and high blood pressure 
before their convulsions. Some survivors had convulsions at home before delivery.  
Knowledge of high blood pressure and convulsions during pregnancy 
Most survivors reported that they did not know about the significance of high blood pressure and convulsions. 
They had never heard about these danger signs, nor others related to pregnancy.  
Strategies for seeking care 
Despite problems of high blood pressure, women stay at home in the hope the problem is not serious, or they 
visit their village doctors, Imams, and traditional or spiritual healers. After they start convulsing, relatives rush 
women to a hospital for treatment. All survivors reported that, after seeing them, their initial service providers 
referred them to another hospital. No providers retain PE/E patients at their hospital, and skip emergency 
management. This situation is true for all PHC, and most secondary and private clinics, because of providers’ 
fear of expected poor outcomes and relatives’ reactions. This moving of eclamptic women from one hospital to 
another results in long delays (10 to 20 hours) before finally reaching a tertiary hospital, where, sometimes, it is 
too late to initiate the required intervention.  
CASE STUDY 
We interviewed a 19 year old housewife, who had gone to school through the ninth grade, married when she 
was 18 years old, and had her first baby by caesarian section. She lives in a district town of Tangail, with her in-
laws. There are several hospitals near her house. It takes 20 minutes to reach the nearest government or district 
hospital, but it takes only 10 minutes to reach the nearest clinic. She conceived within three months of her 
marriage and attended the Janata clinic for her first check up and sonogram at eight months of gestation. A 
female doctor checked her blood pressure and gave her a blood test. Her blood pressure was low, and the doctor 
suggested a nutritious diet and monthly check up; she also told her not to worry and suggested normal delivery. 
She had had swollen legs in her seventh month of pregnancy and headaches, but the doctor didn’t say anything 
about it.  
Her convulsions started at midnight before delivery, and she was immediately taken to the district hospital. She 
received an injection to reduce the convulsions, but her condition did not improve. As it was a Friday, the doctor 
was not available. She was then referred to Mirzapur Kumudini Hospital (a private hospital) for better treatment, 
but there was no doctor available, as it was a Friday. One female nurse suggested her family to take her to Dhaka 
Medical College Hospital (DMCH), but she was taken to another clinic in Tangail, as DMCH was too far from their 
home. The Tangail clinic sent her home. Her condition did not improve, and she was taken to DMCH by 
ambulance and had a caesarian section. At the time of the interview, she was slowly recovering and the baby 





This cross sectional study identifies the policy and program activities, gaps, and challenges for PE/E prevention 
and treatment as well as the MgSO4 loading dose regimen in Bangladesh. It also analyzes the gaps and 
challenges faced by providers and facilities, and their capacities for preventing, detecting, and managing PE/E, 
to assess community PE/E awareness, beliefs, and experiences, including eclampsia survivors, to determine the 
barriers to care and priority areas for research and programs for improving access to PE/E prevention and 
management.  
POLICY  
National polices for maternal health and a Standard Operating Procedure (SOP) encompass prevention and 
management of PE/E, but no discrete polices exist for PE/E. Bangladesh’s SOPs enable only doctors and nurses 
to administer MgSO4 to women with PE/E, and at secondary and tertiary levels. Nurses, however, can only 
administer it following doctors’ advice or prescription. Task sharing with PHC providers (FWVs and SACMOs) to 
administer an intramuscular loading dose of MgSO4 before referral has recently been approved, based on the 
evidence of studies by OGSB and Population Council as well as Save the Children, both in 2015. This approval 
has not been widely disseminated, however, evinced by the lack of awareness and confusion about it observed 
among most study participants. One major gap results from the fact that national policies are not adequately 
communicated to the district level and their facilities.  
Doctors, policy makers, and program managers expressed similar opinions on the policy for anti-hypertensive 
drugs. Lower level cadres are not allowed to prescribe anti-hypertensives in Bangladesh, but many do prescribe 
them. Without a policy for PHC providers’ legal administration of anti-hypertensives to pregnant women, they are 
not properly trained about which drugs can and cannot be given during pregnancy. Primary providers 
inappropriately prescribe anti-hypertensive drugs that indicate their inability to classify and determine the 
severities of hypertensive disorders in pregnancy. Similar findings were also observed for some doctors. In 
Bangladesh anti-hypertensive drugs for mild to moderate hypertension (Methyldopa and Nifedipine) as well as 
severe hypertension (hydralazine) are cheap and easily available, but Labetalol is expensive and not easily 
accessible; Hydralazine is an intravenous drug PHC providers are not allowed to administer. Knowledge gaps 
have also been observed among providers about when to initiate which drugs. Future interventions targeting 
health providers should include training on the selection of anti-hypertensives for pregnant women with varying 
degrees of PE/E.  
Few policy makers or providers were aware of aspirin prophylaxis for pregnant at high risk of PE/E. In fact, there 
is no policy on use of aspirin as prophylaxis in such cases. PHC providers in Bangladesh are not allowed to 
prescribe aspirin; in reality they do recommend it for other ailments. Most policy makers, program managers, 
and providers are apparently unaware of aspirin’s prophylactic use PE/E, which is a clear gap in provider 
knowledge. No service providers mentioned calcium as a PE/E prophylaxis, possibly because calcium is regularly 
supplied to facilities for pregnant women as a standard “supplement,” not as prophylaxis for PE/E. Obstetricians 
have reservations about sharing responsibilities for aspirin prophylaxis with PHC providers; they suggested that 
PHC providers should instead refer those cases to doctors. Obstetricians apparently want to keep those cases 
under their expert supervision, suggesting PHC providers prescribe calcium for PE/E prevention.  
Policy makers and program managers should ensure that facilities are supported with the necessary guidelines, 
job aids, and BCC materials, which are lacking in most facilities, to help their PE/E management and improve 
their overall quality of care. Providers at all levels are not reliably taking antenatal clients’ medical histories, 
especially in relation to PE/E. Managers should focus their efforts on improving provider antenatal care 




HEALTH SYSTEM  
All facilities surveyed provide antenatal, delivery, and postnatal services. While services for preventing and 
managing PE/E exist in secondary and tertiary facilities, PHC centers lack essential commodities and equipment 
for PE/E services. Many facilities, particularly PHCs, lack materials necessary for emergency response. Many  
secondary facilities do not provide their expected levels of PE/E services due to lack of trained and skilled 
providers, no MgSO4 in stock (DGFP never supplied MgSO4 to its facilities), or other essential equipment. In some 
facilities, MgSO4 remains underutilized due to lack of PE/E patients. Although MCWCs (secondary facilities), 
conduct normal and caesarian deliveries, they do not appear to always stock MgSO4 and are obliged to refer 
PE/E women to district hospitals. DGHS supplies MgSO4, calcium gluconate, and anti-hypertensives (Losartan 
potassium, Atenolol, Amlodipine, Methyldopa) to its facilities, but calcium gluconate is rarely found in secondary 
facilities, and in reality, few have any of those drugs in stock. When required, upazila or DGFP district managers 
can purchase a drug from the local market, or patients are advised to purchase it from the pharmacy or market. 
PHC centers see few women with PE/E, with PE/E patients at secondary facilities even lower. Communities’ lack 
of confidence in PHC and secondary facilities leads to delays in seeking care until the condition becomes serious 
and they are forced to rush to tertiary facilities.  
Doctors’ knowledge of the signs and symptoms of eclampsia’s various manifestations is satisfactory, and 
reasonably good among other cadres. Despite demonstrating high levels of knowledge, however, service 
providers are not routinely screening for PE/E and miss opportunities to identify and effectively manage cases. 
A number of doctors and other cadres, particularly at the PHC level, are confused about the signs and symptoms 
and reported insignificant signs and symptoms, indicating that their future training should include PE/SPE/E in 
detail.  
Evidence supports the recommendation of MgSO4 as the best strategy for preventing and treating convulsions 
in severe PE/E. While it is imperative that service providers know which drugs should be used for effective 
management, only one third of doctors know MgSO4’s loading and maintenance doses. Oladapo et al. reports, 
that due to poor provider knowledge, ”It is not surprising that these pregnancy complications account for more 
maternal deaths than any other causes, including postpartum hemorrhage” (2015). While service providers 
should be adequately trained to administer MgSO4 at the right time and with the proper doses, they also need 
to know the warning signs for MgSO4 toxicity and the proven antidote, calcium gluconate. Currently, this 
knowledge is lacking.  
As expected, only about one third of doctors currently use MgSO4 and report its availability at their facilities. The 
reasons for its lack of availability are numerous: insufficient supplies, lack training, not allowed to prescribe it, 
and uncertainty about its indications. When there is no supply, purchasing MgSO4 from a market is the only 
reliable option for service providers, however, they—incorrectly—see Diazepam or Phenobarbitone as alternative 
options. Many providers use inappropriate drugs as alternatives when MgSO4 is unavailable, which strongly 
indicates that providers need more training. Many service providers reported their lack of training, lack of 
knowledge of side effects, lack of equipment and supplies, need for doctor supervision, fear of community 
reaction if a patient dies after being given MgSO4, and lack of monitoring as barriers to administering a loading 
dose of MgSO4.  
Facility documentation is poor in almost all facilities. Many essential elements are missing from registration, 
patient histories, diagnosis, and treatment. To draw conclusions from service statistics, disease profiles, client 
presentations and demographics, service providers must take detailed histories that are properly documented 
in the prescribed forms. These gaps only can be improved by regular supervision and monitoring.  
COMMUNITY  
Most clients were satisfied with their services, although many essential elements were missing from their care. 




Another possible reason could be their low levels of education and lack of awareness of their rights and the 
availability of services. 
Over the last three decades the status of women has improved for various aspects: social, economic and 
empowerment. A vast majority of women, however, are still dependent upon the decisions of their mothers-in-
law and husbands about seeking health care outside of the home and visiting health care providers (BMMS 
2010, BDHS 2014). Study findings suggest that mothers-in-law and husbands consult with Imams, kobiraj or 
traditional or spiritual healers, or village doctors for problems during pregnancy. Pregnant woman are taken to 
health facilities only when a problem becomes truly serious. Other factors negatively affecting health seeking 
behaviors for PE/E patients include lack of money, lack of transportation, distance to hospitals, lack of proper 
attention and care at hospitals, lack of qualified doctors, and restrictions from mothers-in-law (Population Council 
2015).  
Many beliefs and misconceptions about pregnancy exist in communities; often, pregnant women cannot go 
outside, eat certain foods, or are required to eat other foods, and many women are not allowed to take modern 
medicine during pregnancy. Community members and pregnant women lack awareness and knowledge of pre-
eclampsia and eclampsia danger signs, particularly high blood pressure. Many pregnant women are not even 
informed about danger signs during their antenatal care visits. Convulsions during pregnancy are a life-
threatening problem, but many community members consider it a “problem of evil eyes.” Policy makers and 
program managers must understand the significance of these factors so they can make greater efforts to 
educate community members through various mechanisms including regular health worker visits to 
communities, meetings with husbands and wives together, and meetings with mothers-in-law or older people, 
as part of a whole community mobilization effort.  
An unclear picture about referrals and their relevant facilities prevails both among service providers and within 
communities. According to many pre-eclampsia survivors, they did not receive proper, timely, and adequate 
treatment at lower and secondary level facilities and were referred from one facility to another, in both the public 
and private systems.  
Policy makers need to give urgent attention to determining why seriously ill eclamptic patients are being refused 
treatment by public secondary facilities and private clinics, and develop a strategy to improve the situation. 










Conclusions and recommendations 
This section presents the gaps and challenges identified throughout this landscape analysis and draws 
conclusions from the various national and district studies examined. It also provides recommendations for the 
prevention and management of pre-eclampsia and eclampsia, and reduction of those gaps and challenges.  
TABLE 17  Conclusions and recommendations 
Identified Gaps and Conclusions Recommendations 
Policy  
• Policies for PE/E prevention and management 
exist within the broader maternal health strategy 
but many providers are unaware of the policies 
or don’t place any importance on them.  
• Government PE/E policy and guidelines should be 
adequately communicated to all related 
stakeholders, program managers, and service 
providers.  
• The policy environment is conducive for task 
sharing for PE/E prevention and management—  
to PHC providers with proper training and 
mentoring.  
• A policy document is required, for distribution 
throughout the health system, including PHC 
facilities.  
• Clinical practices for PE/E prevention and 
management are established at the tertiary 
level, but variably at the secondary level. PHC 
level facilities do not have any PE/E protocols.  
• Policy should be set for secondary facilities’ 
uniform clinical practice of PE/E prevention 
and management, and secondary providers 
should be trained according to it, as well as 
PHC providers.  
• PHC providers are not allowed to provide aspirin 
or anti-hypertensive drugs for PE/E prevention 
and treatment.  
• Policy decision should commence on the 
introduction of aspirin and antihypertensive 
drug use by PHC providers.  
• A user-friendly loading dose of MgSO4 is not 
available, and the non-existence of a single 
loading dose of MgSO4 (IM) is a barrier to proper 
and timely use.  
• Government policy and persuasion  
with pharmaceutical companies is necessary  
for production of single IM loading dose of MgSO4.  
Health system 
Knowledge 
• Service providers, including physicians, lack 
knowledge of MgSO4, PE/E preventive drugs 
(aspirin and calcium), appropriate anti-
hypertensive drugs, signs of MgSO4 toxicity, 
calcium gluconate, and PE/E signs and 
symptoms.  
• All levels of service providers should be properly 
trained on broader MNH issues, particularly PE/E, 
to build their confidence and skills for its 
prevention, detection, management. Training 
should also include emergency management of 
premature births and referrals as well.  
• ANC consultation should be an opportunity  
to improve PE/E prevention, detection, 
management and referral through regular blood 
pressure measurement and urine testing.  
• All PHC providers as well as other axillary staff 
lack knowledge and skills for PE/E detection, 
prevention, management.  
• Review and revise curricula for Nurses, midwives, 
FWVs, SACMOs and other paramedics.  
• Secondary facility providers lack essential PE/E 
knowledge and skills.  
• Relevant service providers at secondary  
or referral facilities should be thoroughly 
training trained on PE/E prevention, 
detection, management.  
• PE/E management protocol should be  




Identified Gaps and Conclusions Recommendations 
Practice 
• Low use of MgSO4 due to poor screening and 
detection leading to a low number of properly 
identified patients.  
• ANC, delivery, and PNC service providers 
should screen every patient for increased 
blood pressure and assess PE/E risk.  
• Low detection of PE/E patients by PHC and 
secondary facility providers during ANC and PNC 
consultations due to service providers’ lack of 
knowledge, skills, low confidences, poor 
logistical support, lack of accountability, and 
reluctance 
• Service provider capacity needs strengthening  
in regular refresher training, with competency-
based training recommended.  
• A checklist can assess PE/E risk and initiate 
prophylactic treatment using calcium and aspirin.  
• PHC providers (FWVs and SACMOs) must be 
mentored by a referral provider.  
• Low levels of detection of PE/E and high risk 
patients in communities and resultant low levels 
of referral  
• Field workers, supervisors, and program managers 
should be oriented on PE/E patient identification 
in the community and the importance of timely 
referral.  
• Poor history taking • Supervisors should ensure service providers 
correctly and adequately take the client history.  
• Inappropriate anti-hypertensive and 
anticonvulsant drugs  
• To reduce the unhealthy practice providers should 
be thoroughly trained on choice of anti-
hypertensive drugs and anticonvulsant drugs.  
Training 
• Service providers particularly, PHC providers, 
lack essential skills in administering MgSO4, 
measuring blood pressure, testing urine 
albumin, assessing PE/E risk, and emergency 
management.  
• Competency-based training should be organized 
for all PHC service providers, with a refresher 
training after three months.  
• Provider training should include selection of anti-
hypertensive drugs with varying degrees of PE/E.  
• Lack of organized PE/E training  
 
• Cascade training on PE/E for all service providers 
is recommended.  
• A PE/E component should be incorporated in 
ongoing trainings.  
• Orientation of program managers and field 
workers is also recommended to ensure their 
understanding of the importance of PE/E 
prevention, detection, management.  
Service provision 
• Many secondary facilities are not providing PE/E 
services instead refer to District Hospital.  
• All secondary facilities should provide PE/E 
services, as time and distance to another 
referral facility affects outcomes.  
• NGOs are working on improving maternal health 
and their reach is wide, but most are not 
focusing their efforts on PE/E prevention and 
management.  
• All stakeholders should be involved in preventing 
and managing PE/E through a national network.  
• PE/E patients seen during ANC, as well as PNC, 
at most facilities are referred to District 
Hospitals and medical colleges.  
• Decentralized service provision should be 
established, with appropriate training,  
with essential equipment and commodities at PHC 
facilities to improve PE/E outcomes resulting due 




Identified Gaps and Conclusions Recommendations 
• Lack of proper documentation of clients’ details 
and differential diagnoses  
• Strong technical and supportive supervision and 
monitoring of service providers to ensure proper 
documentation through immediate supervisors.  
• Many essential elements of documentation are 
missing from the registration, history taking, 
diagnosis and treatment.  
• Ensure strong technical and supportive 
supervision and monitoring the of PHC service 
providers.  
• Lack of supervision, monitoring and review of 
performance.  
• District managers should lead a monthly review  
of PE/E cases detected and referrals to ensure 
client follow up and recommendations for the 
initial service providers.  
• Other supervisors should visit a facility each 
month for supervision and monitoring.  
Supplies and commodities 
• There is an irregular supply/lack of supply or no 
supply of MgSO4, calcium, calcium gluconate, 
anti-hypertensive drugs, BP machines, test 
tubes, dipsticks, patella hammers at the PHC 
facilities as well as the referral facilities to 
prevent, detect and manage PE/E patients.  
• MoHFW should ensure regular supply of all 
equipment and commodities at facilities  
to prevent, detect and manage PE/E 
patients, and monitor their availability 
periodically.  
• Anti-hypertensive drugs (Losartan potassium, 
Atenolol, Amlodipine, Methyldopa) are irregularly 
available through the public supply system only 
to the secondary level and above.  
• Regular supply of these anti-hypertensive 
drugs should be made available in facilities.  
• Lack of emergency materials in the PHC centers 
and many secondary facilities.  
• Program managers are unaware of shortages of 
essential equipment and commodities.  
• Essential emergency materials need to be 
made available in all facilities. District 
program managers need to, and should, 
monitor them regularly.  
• Protocol/algorithm on PE/E detection and 
management for PHC providers is complex.  
• Review and revise the PE/E protocol and 
algorithm.  
Referrals 
• The referral system is poor, and even non-
functional, with no system for tracking or 
following up with PE/E clients.  
 
• Strengthen referral system by identifying local 
facilities and assessing their readiness and 
ensuring lower level provider readiness to identify 
referral facilities in relation to their facilities.  
• SPE/E patients do not receive adequate 
treatment or any treatment at all in lower level 
facilities; they are referred from one facility to 
another until they finally end up at a tertiary 
facility or medical college, often when too late.  
• MoHFW intervention is needed to ensure patients 
do not experience undue stress and logistical 
challenges and get appropriate treatment.  
• The root causes of such problems need to be 
identified.  
Community 
• Lack of community awareness of the importance 
of regular ANC visits.  
 
• Community awareness of ANC services as well as 
PE/E should be improved by using public 
representatives, religious leaders, imams, priests, 
local government, health workers, and ICT and 
BCC materials.  
• Misperceptions and misbeliefs about PE/E are 
prevalent in the community.  
• Misperceptions and misbeliefs should be 
reduced through mass media as well as 




Identified Gaps and Conclusions Recommendations 
• Health seeking behaviors for pregnancy 
complications follow a pattern: First 
mothers-in-law or husbands take a 
pregnant woman for suggestions from the 
imam, traditional or spiritual healers; then 
they visit a village doctor; and finally they 
attend a secondary or tertiary facility when 
the complication becomes more serious.  
• Community people should be aware about 
the signs, symptoms and dangers of PE/E 
and need of ANC and timely treatment of 
PE/E through mass media and interpersonal 
communication.  
Further research 
• Further implementation research is necessary 
for identifying programmatic problems and 
solutions for PE/E prevention, detection, and 
management. This landscape analysis raised 
some research questions that are important for 
examining to enrich our understanding of PE/E.  
• Are PHC providers capable of identifying pregnant 
women at risk of developing PE/E and providing 
prophylactic aspirin? 
• Will a simple tool assist PHC provider identification 
of pregnant women at risk of developing PE/E,  
for proper detection, management, referral? 
• What happens to women sent to a referral facility 
with or without a loading dose of MgSO4? 
• What is the best approach for improving referral 
linkages? 
• Will an ICT-based mentoring system for PHC 
service providers be feasible and effective? 
• Does water salinity in coastal areas increase PE/E 
risk?  
• Are PHC service providers capable of identifying 
hypertensive disorders in pregnancy and 
appropriately prescribing anti-hypertensive drugs? 
• Do women think treatment is complete  
after a loading dose of MgSO4? What happens  
to them at home?  
• Why are seriously ill eclamptic or SPE patients 
being refused services by secondary facilities  
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